Search Results - Lisa Flammini
- Showing 1 - 10 results of 10
-
1
-
2
Effects of CCL20/CCR6 Modulators in a T Cell Adoptive Transfer Model of Colitis by Marika Allodi, Lisa Flammini, Carmine Giorgio, Maria Grazia Martina, Francesca Barbieri, Vigilio Ballabeni, Elisabetta Barocelli, Marco Radi, Simona Bertoni
Published in Pharmaceuticals (2025-09-01)Get full text
Article -
3
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases by Davide D’Angelo, Stefania Glieca, Lisa Flammini, Simona Bertoni, Annalisa Bianchera, Eride Quarta, Ben Forbes, Fabio Sonvico, Francesca Buttini
Published in Pharmaceutics (2026-05-01)Get full text
Article -
4
UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling by Carmine Giorgio, Marika Allodi, Simone Palese, Andrea Grandi, Massimiliano Tognolini, Riccardo Castelli, Alessio Lodola, Lisa Flammini, Anna Maria Cantoni, Elisabetta Barocelli, Simona Bertoni
Published in Pharmaceuticals (2021-05-01)Get full text
Article -
5
Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats. by Federica Vacondio, Michele Bassi, Claudia Silva, Riccardo Castelli, Caterina Carmi, Laura Scalvini, Alessio Lodola, Valentina Vivo, Lisa Flammini, Elisabetta Barocelli, Marco Mor, Silvia Rivara
Published in PLoS ONE (2015-01-01)Get full text
Article -
6
Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD by Andrea Grandi, Irene Zini, Simone Palese, Carmine Giorgio, Massimiliano Tognolini, Francesco Marchesani, Stefano Bruno, Lisa Flammini, Anna Maria Cantoni, Riccardo Castelli, Alessio Lodola, Antonella Fusari, Elisabetta Barocelli, Simona Bertoni
Published in Frontiers in Pharmacology (2019-06-01)Get full text
Article -
7
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro by Davide D’Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, Francesca Buttini
Published in Pharmaceutics (2023-03-01)Get full text
Article -
8
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC by Silvia La Monica, Roberta Minari, Daniele Cretella, Lisa Flammini, Claudia Fumarola, Mara Bonelli, Andrea Cavazzoni, Graziana Digiacomo, Maricla Galetti, Denise Madeddu, Angela Falco, Costanza Annamaria Lagrasta, Anna Squadrilli, Elisabetta Barocelli, Alessandro Romanel, Federico Quaini, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri
Published in Journal of Experimental & Clinical Cancer Research (2019-05-01)Get full text
Article -
9
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells by Valentina Coccè, Silvia La Monica, Mara Bonelli, Giulio Alessandri, Roberta Alfieri, Costanza Annamaria Lagrasta, Denise Madeddu, Caterina Frati, Lisa Flammini, Daniela Lisini, Angela Marcianti, Eugenio Parati, Francesca Paino, Aldo Giannì, Giampietro Farronato, Angela Falco, Lorenzo Spaggiari, Francesco Petrella, Augusto Pessina
Published in Cells (2021-06-01)Get full text
Article -
10
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models by Silvia La Monica, Federica Vacondio, Kamal Eltayeb, Alessio Lodola, Francesco Volta, Martina Viglioli, Francesca Ferlenghi, Francesca Galvani, Maricla Galetti, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Lisa Flammini, Michela Verzè, Roberta Minari, Pier Giorgio Petronini, Marcello Tiseo, Marco Mor, Roberta Alfieri
Published in Scientific Reports (2024-03-01)Get full text
Article
